Clinical Trials Directory

Trials / Unknown

UnknownNCT02553278

VelaShape and Contour I V3 for Abdominal Fat Reduction vs. Control

Clinical Study to Evaluate the Performances of Modified VelaShape and the Performance of Contour I V3 Devices for Abdominal Fat Reduction vs. Control

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Syneron Medical · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Prospective, 2-arm, clinical study for the evaluation of the VelaShape device and Contour I V3 device for non-invasive fat reduction vs. control. All study subjects, who are scheduled for abdominoplasty, will undergo one treatment with VelaShape or Contour I V3 device. Each arm will be treated with a different device: Arm 1: subject will treated with VelaShape device Arm 2: subject will treated with Contour I V3 device

Detailed description

Eligible subjects will undergo one treatment on one abdominal subarea. Another abdominal subarea will remain without treatment and will serve as a control. Biopsies from treated and untreated areas will be harvested during abdominoplasty and cultured.. Treatment with VelaShape will be performed to arm 1, and treatment with Contour I V3 will be performed to arm 2, according to the study protocol. Each arm will be divided into 6 sub-groups, according to the following time interval between VelaShape or UltraShape treatment to surgery: Sub-group 1: Surgery immediately after treatment Sub-group 2: Surgery 10 days after treatment Sub-group 3: Surgery 20 days after treatment Sub-group 4: Surgery 30 days after treatment Sub-group 5: Surgery 60 days after treatment Sub-group 6: Surgery 90 days after treatment Each Sub-group contains up to 2 subjects.

Conditions

Interventions

TypeNameDescription
DEVICEVelaShape deviceModified VelaShape radiofrequency device for non invasive fat reduction treatment.
DEVICEContour I V3 deviceContour I V3 device are non invasive for fat reduction.

Timeline

Start date
2016-01-10
Primary completion
2017-10-01
Completion
2017-12-01
First posted
2015-09-17
Last updated
2017-04-10

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02553278. Inclusion in this directory is not an endorsement.